News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Shaheenah Dawood: Phase 2 RAMP201 Trial Leading to FDA Accelerated Approval of Avumetinib and Defactinib
Shaheenah Dawood/LinkedIn
Jul 13, 2025, 13:27

Shaheenah Dawood: Phase 2 RAMP201 Trial Leading to FDA Accelerated Approval of Avumetinib and Defactinib

Shaheenah Dawood, Consultant Medical Oncologist at Mediclinic Middle East, shared a post on LinkedIn:

“Phase 2 RAMP201 (ENGOTov60/GTG-UK/GOG3052)trial leading to FDA accelerated approval avumetinib and defactinib now published.”

Title: Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201

Authors: Susana N. Banerjee, Els Van Nieuwenhuysen, Carol Aghajanian, Véronique D’Hondt, Bradley J. Monk, Andrew Clamp, Emily Prendergast, Ana Oaknin, Kari Ring, Nicoletta Colombo, Robert W. Holloway, Manuel Rodrigues, Hye Sook Chon, Charlie Gourley, Alessandro D. Santin, Premal H. Thaker, Christine Gennigens, Gregg Newman, Erin Salinas, Hagop Youssoufian, Kathleen N. Moore, Stephanie Lustgarten, David M. O’Malley, Toon Van Gorp, Rachel N. Grisham

Read Full Article on Journal of Clinical Oncology.

Shaheenah Dawood

More posts featuring Shaheenah Dawood on OncoDaily.

Alessandro D. Santin Ana Oaknin Andrew Clamp Bradley J. Monk cancer Carol Aghajanian Charlie Gourley Christine Gennigens David M. O'Malley Els Van Nieuwenhuysen Emily Prendergast Erin Salinas Gregg Newman Hagop Youssoufian Hye Sook Chon Kari Ring Kathleen N. Moore Manuel Rodrigues Nicoletta Colombo OncoDaily Oncology Premal H. Thaker Rachel N. Grisham Robert W. Holloway Stephanie Lustgarten Susana N. Banerjee Toon Van Gorp Véronique D’Hondt
Special Coverage
Voices
Aug 24, 2025, 11:46
Eric Bouffet: Running for Childhood Cancer Support with GFAOP on September 28
OncoDaily Pulse
Aug 24, 2025, 11:32
Yu-Wei Chen: Meet the Experts of VIRO 2025
Voices
Aug 24, 2025, 11:25
David Skorton Shared a Study on Mortality Disparities Among Women Physicians
OncoDaily Pulse
Aug 24, 2025, 11:24
Yousef Zakharia: Meet the Experts of VIRO 2025
Insight
Aug 24, 2025, 11:21
Gustave Roussy Research Shares a Study on TALAPRO-2 as a New Standard of Care in mCRPC
Voices
Aug 24, 2025, 11:15
Wafik El-Deiry Advocates for State Support of Cancer Research to Better Serve Rhode Island Communities
Oncolibrary
Aug 24, 2025, 10:59
Mapping the World’s Highest and Lowest Cancer Rates
Insight
Aug 24, 2025, 10:59
George Kumar: Lymphoma Accelerates T Cell and Tissue Aging
Voices
Aug 24, 2025, 10:42
Shrenik Shah Became a Finalist for the Community Cultivator Award in the 2025 Social Health Awards
Voices
Aug 24, 2025, 10:29
Simone Cesaro: The Management of Cytomegalovirus Infection in Pediatric Allo-HSCT
Societies
Aug 24, 2025, 09:59
Advanced Care Oncology Center Joins EIOC 2025 as Support Sponsor
Voices
Aug 24, 2025, 08:50
Maria Tolia Shares an Article on High-Risk Prognostic Factors for Breast Cancer Recurrence Post-Mastectomy